R

Retrotope, Inc.

13 employees

Retrotope is a developer of a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Medical
Drug Discovery

Date founded

2006

Funding rounds raised

Total raised

$20M

from 5 investors over 5 rounds

R

Retrotope, Inc. raised $20M on November 30, 2018

Investors: Morningside Venture Capital 晨兴资本

R

Retrotope, Inc. raised $10M on January 15, 2015

Investors: North Texas Angel Network, Life Science Angels, Green Park & Golf Ventures and Sdl Ventures

FAQ